Showing results (151-160 of 454) with videos related to
Sort By:
Pageof 46
Cancer Chemotherapy and Pharmacology|June 1, 2010
Phase I-II trial of prolonged gemcitabine infusion plus paclitaxel as a biweekly schedule for advanced breast cancer patients pretreated with anthracyclinesPatrizia Vici, Alessandra Fabi, Giulio Metro, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 15, 2008
Oral ondansetron is highly active as rescue antiemetic treatment for moderately emetogenic chemotherapy: results of a randomized phase II studyAlessandra Fabi, Mariangela Ciccarese, Giulio Metro, et al.BMC Cancer|October 23, 2012
Maintenance bevacizumab beyond first-line paclitaxel plus bevacizumab in patients with Her2-negative hormone receptor-positive metastatic breast cancer: efficacy in combination with hormonal therapyAlessandra Fabi, Michelangelo Russillo, Gianluigi Ferretti, et al.Cancers|February 25, 2022
Oncologic Drugs Approval in Europe for Solid Tumors: Overview of the Last 6 YearsRosa Falcone, Pasquale Lombardi, Marco Filetti, et al.Breast (Edinburgh, Scotland)|May 3, 2008
Do HER-2 positive metastatic breast cancer patients benefit from the use of trastuzumab beyond disease progression? A mono-institutional experience and systematic review of observational studiesAlessandra Fabi, Giulio Metro, Gianluigi Ferretti, et al.The Journal of Organic Chemistry|April 13, 2005
Fluorinated heterocyclic compounds. An effective strategy for the synthesis of fluorinated Z-oximes of 3-perfluoroalkyl-6-phenyl-2h-1,2,4-triazin-5-ones via a ring-enlargement reaction of 3-benzoyl-5-perfluoroalkyl-1,2,4-oxadiazoles and hydrazineSilvestre Buscemi, Andrea Pace, Antonio Palumbo Piccionello, et al.Cancer Letters|October 13, 2019
The influence of patient sex on clinical approaches to malignant gliomaSilvia Matteoni, Claudia Abbruzzese, Veronica Villani, et al.Genetics in Medicine Open|January 6, 2026
CFTR rescue in W1282X cystic fibrosis patient-derived intestinal organoids (PDIOs) mediated by translational readthrough-inducing drugs (TRIDs)Riccardo Perriera, Anabela S Ramalho, Francois Vermeulen, et al.Journal of Clinical Medicine|December 23, 2023
Total Ankle Replacement Infections: A Systematic Review of the LiteratureRenato Zunarelli, Michele Fiore, Gianluca Lonardo, et al.The Journal of Biological Chemistry|March 26, 2003
Phosphospecific site tyrosine phosphorylation of p125FAK and proline-rich kinase 2 is differentially regulated by cholecystokinin receptor type A activation in pancreatic aciniAndrea Pace, Luis J García-Marin, Jose A Tapia, et al.Pageof 46